Inventor
WU WEN-LIAN
US37 patents
⚠️ This page may combine multiple inventors who share the name “WU WEN-LIAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SCHERING CORP
13 patentsUS6664273B2Dec 16, 2003
Piperidine based MCH antagonists for treatment of obesity and CNS disorders
SCHERING CORP45 citations92
US7482360B2Jan 27, 2009
Fused tetracyclic mGluR1 antagonists as therapeutic agents
SCHERING CORP15 citations84
US7109207B2Sep 19, 2006
Spirosubstituted piperidines as selective melanin concentrating hormone receptor antagonists for the treatment of obesity
SCHERING CORP13 citations83
US7598259B2Oct 6, 2009
mGluR1 antagonists as therapeutic agents
SCHERING CORP2 citations61
US7214691B2May 8, 2007
2-substituted benzimidazole derivatives as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
SCHERING CORP6 citations61
US7211574B2May 1, 2007
Selective D1/D5 receptor antagonists for the treatment of obesity and CNS disorders
SCHERING CORP1 citations52
US7989464B2Aug 2, 2011
mGluR1 antagonists as therapeutic agents
SCHERING CORP0 citations50
US7485648B2Feb 3, 2009
mGluR1 antagonists as therapeutic agents
SCHERING CORP1 citations50
US7767815B2Aug 3, 2010
Fused tricyclic mGluR1 antagonists as therapeutic agents
SCHERING CORP0 citations41
US7498441B2Mar 3, 2009
Biaryltetrahydroisoquinoline piperidines as selective MCH receptor antagonists for the treatment of obesity and related disorders
SCHERING CORP0 citations41
US7511146B2Mar 31, 2009
2-substituted benzimidazole piperidines analogs as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders
SCHERING CORP0 citations38
US6903123B2Jun 7, 2005
Azetidinyl diamines useful as ligands of the nociceptin receptor ORL-1
SCHERING CORP0 citations37
US7423149B2Sep 9, 2008
Substituted n-aryl amidines as selective D1 dopamine receptor antagonists for the treatment of obesity and CNS disorders
SCHERING CORP0 citations36
MERCK SHARP & DOHME
11 patentsUS10689401B2Jun 23, 2020
C5-C6-oxacyclic fused iminothiazine dioxide compounds bearing an ether linker as BACE inhibitors, compositions, and their use
MERCK SHARP & DOHME2 citations72
US9365589B2Jun 14, 2016
C5, C6 oxacyclic-fused thiazine dioxide compounds as BACE inhibitors, compositions, and their use
MERCK SHARP & DOHME7 citations71
US11008338B2May 18, 2021
C5-C6-oxacyclic fused iminothiazine dioxide compounds bearing an ether linker as BACE inhibitors, compositions, and their use
MERCK SHARP & DOHME0 citations62
US10414774B2Sep 17, 2019
Compound useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolc disease
MERCK SHARP & DOHME1 citations61
US11466047B2Oct 11, 2022
Cyclic di-nucleotide compounds as sting agonists
MERCK SHARP & DOHME0 citations52
US9453034B2Sep 27, 2016
C2-azaspiro iminothiazine dioxides as BACE inhibitors, compositions, and their use
MERCK SHARP & DOHME2 citations52
US11685761B2Jun 27, 2023
Cyclic di-nucleotide compounds as sting agonists
MERCK SHARP & DOHME0 citations51
US9732088B2Aug 15, 2017
C2-carbocyclic iminothiazine dioxides as BACE inhibitors, compositions, and their use
MERCK SHARP & DOHME1 citations51
US9725468B2Aug 8, 2017
C5-spiro iminothiazine dioxides as BACE inhibitors, compositions, and their use
MERCK SHARP & DOHME0 citations42
US10071998B2Sep 11, 2018
Iminothiadiazine dioxides bearing an amine-linked substituent as BACE inhibitors, compositions, and their use
MERCK SHARP & DOHME0 citations41
US10414775B2Sep 17, 2019
Compounds useful for altering the levels of bile acids for the treatment of diabetes and cardiometabolic disease
MERCK SHARP & DOHME0 citations37
WU WEN-LIAN
6 patentsUS9226927B2Jan 5, 2016
Gamma secretase inhibitors
WU WEN-LIAN8 citations83
US8664411B2Mar 4, 2014
Tetrahydropyranochromene gamma secretase inhibitors
WU WEN-LIAN8 citations82
US9499502B2Nov 22, 2016
5-substituted iminothiazines and their mono- and dioxides as BACE inhibitors, compositions, and their use
WU WEN-LIAN3 citations72
US8933116B2Jan 13, 2015
Gamma secretase inhibitors
WU WEN-LIAN1 citations51
US9181236B2Nov 10, 2015
2-spiro-substituted iminothiazines and their mono-and dioxides as bace inhibitors, compositions and their use
WU WEN-LIAN1 citations46
US9051329B2Jun 9, 2015
Tricyclic heterocycles useful as dipeptidyl peptidase-IV inhibitors
WU WEN-LIAN0 citations40
ANGEX PHARMACEUTICAL INC
3 patentsUS11358949B2Jun 14, 2022
Carbamate and urea compounds as multikinase inhibitors
ANGEX PHARMACEUTICAL INC0 citations47
US11180497B2Nov 23, 2021
Cyclic compounds as immunomodulating agents
ANGEX PHARMACEUTICAL INC0 citations47
US11098046B2Aug 24, 2021
Macrocyclic compounds as TRK kinase inhibitors and uses thereof
ANGEX PHARMACEUTICAL INC0 citations47
ASBEROM THEODROS
2 patentsUS8067621B2Nov 29, 2011
Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
ASBEROM THEODROS5 citations60
US8569521B2Oct 29, 2013
Benzenesulfonyl-chromane, thiochromane, tetrahydronaphthalene and related gamma secretase inhibitors
ASBEROM THEODROS2 citations59